References
- Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997; 25: 1318–26.
- Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbial Rev 1994; 7: 479–504.
- Boutati EI, Anaissie EJ. Fusarium significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood 1997; 90: 999–1008.
- Brint JM, Flynn PM, Pearson TA, Pui CH. Disseminated fusariosis involving bone in an adolescent with leukemia. Pediatr Infect Dis J 1992; 11: 965–8.
- Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35: 909–20.
- Dijk EV, Van den Berg WH, Landwehr AJ. Fusarium solani infection of a hypertensive leg ulcer in a diabetic. Mykosen 1980; 23: 603–6.
- English MP. Invasion of the skin by filamentous non-dermatophyte fungi. British J Derm 1968; 80: 282.
- Nuovo MA, Simmonds JE, Chacho MS, McKitrick JC. Fusarium solani osteomyelitis with probable nosocomial spread. Am J Clin Pathol 1988; 90: 738–41.
- Bourguignon RL, Walsh AF, Flynn JC, Baro C, Spinos E. Fusarium species osteomyelitis. J Bone Joint Surg 1997; 58: 722–3.
- Page JC, Friedlander G, Dockery GL. Postoperative Fusarium osteomyelitis. J Foot Surg 1982; 21: 174–6.
- Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, et al. A large-scale North American study of fungal isolates from nails: the frequency on onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 2000; 43: 641–8.
- Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003; 36: 630–7.